Evaluating a Genetic Variant That Determines Response to Heart Disease Medications
This study will evaluate dogs with heart disease for a common genetic variant to determine whether this variant affects their ability to respond to heart medications.
This study will evaluate dogs with heart disease for a common genetic variant to determine whether this variant affects their ability to respond to heart medications.
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.
This study will determine the genetic and functional differences of eight genes that are strongly associated with congenital extrahepatic portosystemic shunts in several small dog breeds.
This study investigates the effects of topical ophthalmic prednisolone (steroid) and diclofenac (nonsteroidal anti-inflammatory drug) on diabetes mellitus regulation in client-owned dogs.